Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
Treatment options for retinal diseases, such as neovascular age-related macular degeneration, diabetic retinopathy, and retinal vascular disorders, have markedly expanded following the development of anti-vascular endothelial growth factor intravitreal injection methods. However, because intravitrea...
Main Authors: | Hyeong Min Kim, Se Joon Woo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/1/108 |
Similar Items
-
Recent Advances in Ocular Drug Delivery Systems
by: Shinobu Fujii, et al.
Published: (2011-01-01) -
Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature
by: Claudio Iovino, et al.
Published: (2020-07-01) -
New ophthalmic drug delivery systems
by: Ana Castro-Balado, et al.
Published: (2020-07-01) -
A biocompatible reverse thermoresponsive polymer for ocular drug delivery
by: Asitha Balachandra, et al.
Published: (2019-01-01) -
Polysaccharides in Ocular Drug Delivery
by: Natallia Dubashynskaya, et al.
Published: (2019-12-01)